Page 83 - 2024 Catalog - Spring
P. 83

                                hts soFtWare
   The New HTS2 WEB-based Program Allows You to Manage Your Patients’ Program via The Internet
Proven Procedures
HTS2 is a web-based eye exercise program using proven methods of behavior modification in an operant conditioning paradigm.
The program uses random dot stereograms and other objective targets. HTS2 “knows” if your patient has performed the
prescribed exercise session correctly.
Flat Fusion
Patients who cannot appreciate an RDS may be assigned a host of Flat Fusion targets. The patient may select the target they wish to use for each eye exercise session.
Instant Review
Simply log onto HTS2 to see a list of all of your patients. You may view their results, check compliance, modify their program, or send notes right from your computer.
     Total Control
Dispense the HTS2 program in the Auto Mode and the program will automatically advance patients through successive levels of exercises as goals are achieved. The Manual Mode allows you to assign your own custom exercise protocol.
Provides Motivation
HTS2 presents your patients with bar graphs showing exercise goals. Performances from their last and current sessions are displayed. HTS2 virtually “pats the patient on the back” encouraging them to try harder.
Easy Monitoring
The HTS2 program provides graphs depicting each session’s performance. The program displays date, time, duration and performance of each exercise session. HTS2 denotes when your patient has performed the exercise session and also if it was performed correctly.
         NOTE: HTS2 DOES NOT TREAT OR DIAGNOSE ANY SPECIFIC MEDICAL CONDITION OR DISEASE.
 Contact Bernell for pricing or go online at www.bernell.com to order.
 EXAM ROOM NEEDS
 ASSESSMENTS
 OPTICAL
 VISION THERAPY
 NEURO REHABILITATION
 LOW VISION
 REFERENCE
 *oNLy orders froM verified doctor’s accouNts wiLL Be hoNored. orders wiLL droPshiP froM the MaNufacturer.
Order Now by Phone at (574) 259-2070 or Go To www.bernell.com 80
HTS2Bernall Ad.indd 2 1/27/22 9:14 AM
   






































































   81   82   83   84   85